Curis (CRIS) Stock Price, Quote, News & History | Benzinga

SPY761.10−1.39%QQQ707.87−2.77%BTC/USD81,410.89−0.11%DIA518.00−0.59%GLD381.40−0.34%TLT80.06+0.11%

Curis Inc (CRIS) Stock Price, Quote, News & History

CRISNASDAQ

Trade with Public

Trade with Public

$0.4071

-0.10-19.86%

Last update: Oct 16, 7:15 PM

$0.4290

-0.079-15.55%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$0.45

Close

$0.41

Volume / Avg.

1.34M / 200.01K

Day Range

$0.43 - $0.43

52 Wk Range

0.57 - 33.00

Market Cap

$1.45M

P/E Ratio

0.14

Dividend Yield

-

Exchange

NASDAQ

RSI

11

Short Interest

7.46%

Days to Cover

1.02

Recent Curis Inc News

Dow Surges 250 Points; M&T Bank Posts Upbeat Q3 Earnings

U.S. stocks mixed: Dow +0.48%, Nasdaq -0.65%, S&P -0.05%. Energy rose, tech fell, and M&T Bank beat Q3 estimates; oil eased, gold gained.

Avi Kapoor

Why Veea Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket

Veea jumps 34% after regaining Nasdaq compliance; Freight Technologies leads gainers, while Alignment Healthcare plunges 24% among premarket losers.

Avi Kapoor

Curis Gains As Blood Cancer Drug Progresses, December Readout in Focus

Curis gained attention after positive emavusertib data as analyst raised its price target to $43 and highlighted upcoming trial catalysts.

Vandana Singh

Curis Strengthens Oncology Pipeline Outlook With Strong TakeAim Lymphoma Response Rates

Curis shares positive updated clinical data for emavusertib and increases its year-end guidance for the TakeAim CLL study.

Vandana Singh

Why Q32 Bio Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket

Gainers: Q32 Bio up 29.6%, Mint up 75.8%, Fast Track up 58.2%, eLong up 33.4%, Sobr Safe up 29.2%, Eshallgo up 20.3%, Curis up 10.9%, Sky Quarry up 10.6%, Accuray up 9.5%, Bitzero up 5.5%. Losers: Global Mofy down 25.3%, Jiuzi down 22.1%, Julong down 21.4%, Haoxi down 20.4%, Sadot down 20.4%.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-30.59M

Investing Cash Flow (TTM)

2.50M

Financing Cash Flow (TTM)

23.02M

Free Cash Flow (TTM)

-30.59M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-5.07M

Analyst Trends and Forecast

1

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$2.80M

PE Ratio (TTM)

0.14

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.14

PB Ratio (TTM)

0.26

Earnings Yield % (TTM)

718.50%

Earnings Yield % (FWD)

-624.02%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.94

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$5.07M

Debt to Equity

0.22

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-